Report updated Apr 17, 2026
Pill Identifier by Drugs.com
For patients, caregivers, and healthcare professionals seeking quick medication identification and safety information.
Pill Identifier by Drugs.com is a challenged medical app that is free with in-app purchases. With a 3.4/5 rating from 153 reviews, it faces significant user friction. Users particularly appreciate utility for identification, though inaccurate/incomplete database remains a common concern.
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Snap a photo or upload an image to identify pills instantly using advanced recognition technology
Access detailed information on over 24,000 prescription and OTC medications
Search for medications based on imprint, drug name, color, and shape
How much does it cost?
- Free version with basic search
- Pill Identifier Pro: $9.99/week
- Pill Identifier Pro: $29.99/year
The $9.99/week price point is extremely aggressive for a utility app, creating a 'value gap' when the database fails to identify a pill. This model contrasts sharply with WebMD's free, ad-supported approach.
Who Built It?
Drugs.com
Providing peer-reviewed medication information and identification tools to help patients and healthcare professionals manage drug safety.
Portfolio
2
Apps
What other apps does Drugs.com make?
Explore the full Drugs.com report
Portfolio breakdown, audience, momentum, and every app published by Drugs.com.
What do users think recently?
High confidence · Latest 100 of 153 total reviews analyzed · Based on 153 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a frustrated sentiment. Users appreciate utility for identification, but report inaccurate/incomplete database and poor search functionality.
What Users Love
What Frustrates Users
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Pill Identifier by Drugs.com?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
34 active rankings tracked — 30-day window
The rivals identified
The outtake for Pill Identifier by Drugs.com
Strengths to defend, gaps to attack
Core Strengths
- Drugs.com brand authority
- AI-driven photo recognition
- Integration with broader drug info ecosystem
Critical Frictions
- High $9.99/week subscription cost
- Database gaps for common/generic drugs
- Search UI bugs (disappearing filters)
Growth Levers
- Expansion of AI for multi-colored pills
- Professional-tier clinical features
- Offline database access
Market Threats
- Free tools from WebMD
- AI-first startups like Pill Eye
- High churn due to 'no match' results
What are the next best moves?
Fix Search UI Filter Persistence
Users report filters for shape and color disappear when typing imprints, breaking the core search workflow (Sentiment Analysis).
Audit Database for Generic Imprints
High-frequency complaints regarding 'no match' for common drugs like Kenzoflex indicate a database coverage gap that invalidates the Pro subscription value (Sentiment Analysis).
Re-evaluate Weekly Subscription Pricing
The $9.99/week price point is cited as a friction point when technical bugs occur, whereas competitors like Pill Identifier Search offer more stability (Competitor Analysis).
Feature Gaps vs Competitors
- Reliable search for obscure generic imprints (available in Pill Identifier Search)
- Multi-drug interaction analysis (available in Epocrates)
- Offline mode (available in Pillboxie)
Key Takeaways
The app is currently coasting on the Drugs.com brand name but is at high risk of churn due to a 'value gap'—the $9.99/week price is too high for a database that frequently returns 'no match.' To defend its #25 ranking, the PM must prioritize fixing the search UI and expanding the imprint library to match the reliability of the Nemesis, Pill Identifier Search.
Where Is It Heading?
Declining
Upset user sentiment driven by database gaps and UI bugs.
v2.158 (April 2026) update shows active maintenance of the imprint library.
High-friction $9.99/week pricing model creates immediate churn when AI recognition fails.